<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02203201</url>
  </required_header>
  <id_info>
    <org_study_id>ACPM04</org_study_id>
    <nct_id>NCT02203201</nct_id>
  </id_info>
  <brief_title>Diagnostic Significance of Positive EmA Antibodies in the Duodenal Culture Medium of Not-Celiac Wheat Sensitivity (NCWS)</brief_title>
  <acronym>NCWS</acronym>
  <official_title>Diagnostic Significance of Positive Anti-endomysium Antibodies in the Culture Medium of the Intestinal Biopsies in Not-Celiac Wheat Sensitivity (NCWS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Palermo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Palermo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The most frequent diseases caused by wheat ingestion are T cell-mediated disorders, i.e.&#xD;
      celiac disease and immunoglobulin E (IgE)-mediated allergic reactions. However, besides&#xD;
      celiac disease and wheat allergy, there are cases of gluten reactions in which neither&#xD;
      autoimmune nor IgE-mediated allergic mechanisms are involved. These are generally defined as&#xD;
      GS or Not-celiac wheat sensitivity (NCWS). Typically, NCWS diagnosis is made by exclusion,&#xD;
      and an elimination diet and an &quot;open challenge&quot; (i.e., the monitored reintroduction of&#xD;
      gluten-containing foods) are most often used to evaluate whether health improves or worsen&#xD;
      with the elimination or reintroduction of gluten in the diet, respectively. In some&#xD;
      circumstances, it is very difficult to distinguish between NCWS and celiac disease. The&#xD;
      presence of positive celiac disease specific serum antibodies (anti-tissue transglutaminase&#xD;
      (anti-tTG), and anti-endomysium (EmAs) antibodies) is of paramount importance to pose the&#xD;
      diagnosis. However, it is well known that the frequency of a positive serology is dependent&#xD;
      by the severity of the intestinal damage. Consequently, patients with less severe histology&#xD;
      damage (Marsh 1) can have negative serum antibodies. Previous studies had demonstrated that&#xD;
      EmAs are produced by the intestinal lymphocytes and previous data from our group showed that&#xD;
      EmAs assay in the culture medium of the intestinal biopsies has higher diagnostic accuracy&#xD;
      than serum EmAs in diagnosis. Therefore, the aims of our study are to evaluate the&#xD;
      clinical-serologic-histology course of NCWS patients, showing positive EmAs assay in the&#xD;
      culture medium of the duodenal biopsies at the time of the first evaluation, and the&#xD;
      adherence to a gluten-free diet in NCWS patients after a previous full evaluation and a NCWS&#xD;
      diagnosis based on double-blinded placebo-controlled (DBPC) challenge.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Gluten is the most important protein component of some grains, notably wheat, rye, and&#xD;
      barley, which are the basis for a variety of wheat-derived alimentary products consumed&#xD;
      throughout the world (bread, pasta, pizza etc). However the &quot;engineering&quot; of&#xD;
      gluten-containing grains created the conditions for human diseases related to gluten&#xD;
      exposure. These forms of gluten intolerance represent a heterogeneous set of conditions,&#xD;
      including celiac disease, wheat allergy and gluten sensitivity (GS), that, combined, seems to&#xD;
      affect about 10% of the general population.&#xD;
&#xD;
      The immune responsiveness to wheat antigens represents a complex process, and its&#xD;
      establishment and maintenance are not completely elucidated. The most frequent diseases&#xD;
      caused by wheat ingestion are T cell-mediated disorders, i.e. celiac disease and IgE-mediated&#xD;
      allergic reactions. However, besides celiac disease and wheat allergy, there are cases of&#xD;
      gluten reactions in which neither autoimmune nor IgE-mediated allergic mechanisms are&#xD;
      involved. These are generally defined as GS or Not-celiac wheat sensitivity (NCWS), because&#xD;
      it is not known what component of the cereals causes the symptoms. Some subjects, who&#xD;
      experience symptoms when eating gluten-containing products and show improvement when&#xD;
      following a gluten-free diet (GFD) may have NCWS instead of celiac disease or wheat allergy.&#xD;
      NCWS patients are unable to tolerate gluten and develop an adverse reaction when eating&#xD;
      gluten, that, usually, and differently from celiac disease, does not lead to small intestinal&#xD;
      damage. Gastrointestinal symptoms in NCWS patients may resemble those associated with celiac&#xD;
      disease, but the overall clinical picture is generally less severe.&#xD;
&#xD;
      Typically, NCWS diagnosis is made by exclusion, and an elimination diet and an &quot;open&#xD;
      challenge&quot; (i.e., the monitored reintroduction of gluten-containing foods) are most often&#xD;
      used to evaluate whether health improves or worsen with the elimination or reintroduction of&#xD;
      gluten in the diet, respectively.&#xD;
&#xD;
      The frequency of NCWS is however still unknown, even though some studies indicated that it is&#xD;
      higher than that of celiac disease; consequently, it is very probable that this condition&#xD;
      have been undiagnosed and under-diagnosed by the physicians for a long time. However, it is&#xD;
      very difficult, in some circumstances, to distinguish between NCWS and celiac disease. In&#xD;
      fact, NCWS patients can show an intestinal histology characterized by intra-epithelial&#xD;
      lymphocytosis (Marsh 1), a finding considered compatible with a celiac disease diagnosis. In&#xD;
      this difficult, possible, celiac disease diagnosis, the presence of positive specific serum&#xD;
      antibodies (anti-tTG and EmAs) is of paramount importance to pose the diagnosis. However, it&#xD;
      is well known that the frequency of a positive serology is dependent by the severity of the&#xD;
      intestinal damage. Consequently, celiac disease patients with less severe histology damage&#xD;
      (Marsh 1) can have negative serum antibodies. Previous studies had demonstrated that EmAs are&#xD;
      produced by the intestinal lymphocytes and previous data from our group showed that EmAs&#xD;
      assay in the culture medium of the intestinal biopsies has higher diagnostic accuracy than&#xD;
      serum EmAs in celiac disease diagnosis.&#xD;
&#xD;
      Therefore, this study has one major aim: 1. Evaluation of the clinical-serologic-histology&#xD;
      course of NCWS patients showing positive EmAs assay in the culture medium of the duodenal&#xD;
      biopsies at the time of the first evaluation; and one secondary aim: 2. Evaluation of the&#xD;
      adherence to a GFD in NCWS patients after a previous full evaluation and a NCWS diagnosis&#xD;
      based on double-blinded placebo-controlled (DBPC) challenge.&#xD;
&#xD;
      For our research, the investigators will select adult patients, both genders, affected with&#xD;
      NCWS (i.e. with symptoms/signs which disappeared on gluten-free diet and worsen on a gluten&#xD;
      containing diet, testing negative for celiac disease, [anti-tTG and EmAs negative, and with&#xD;
      biopsy Marsh 0-1] and wheat allergy [serum specific IgE for wheat negative]).&#xD;
&#xD;
      The investigators will include exclusively patients who had been previously fully evaluated&#xD;
      for suspected celiac disease in our Hospitals (Department of Internal Medicine, Giovanni&#xD;
      Paolo II Hospital of Sciacca, Agrigento, and of Internal Medicine of the University of&#xD;
      Palermo) from January 2002 to December 2012. In all patients NCWS diagnosis had been posed by&#xD;
      means of a DBPC challenge with wheat flour. At the time of the first evaluation, gluten-free&#xD;
      diet was not prescribed, but simply suggested, as these patients were not considered as&#xD;
      suffering from celiac disease.&#xD;
&#xD;
      The investigators will recruit, as a study group, those NCWS patients who had showed a&#xD;
      negative celiac disease serology and Marsh 0-1 duodenal histology, but who had displayed a&#xD;
      positive EmAs assay in the culture medium of the duodenal biopsies (EmA-biopsy). As control&#xD;
      group, NCWS patients with negative EmA-biopsy will be included.&#xD;
&#xD;
      The investigators will include at least one year before evaluated patients. At the time of&#xD;
      the recruitment it will be evaluated both the adherence to the gluten-free diet, by means of&#xD;
      a previously validated dietary form containing a printed list of the most common foods, and&#xD;
      the symptoms score (Gastrointestinal Symptom Rating Scale, GSRS). Then, the investigators&#xD;
      will re-evaluate the patients for a possible celiac disease diagnosis. Serum anti-tTG IgA and&#xD;
      IgG, anti-deamidated peptides of gliadin (DPG) IgA and IgG, and anti-gliadin (AGA) IgA and&#xD;
      IgG will be assayed. Duodenal biopsies will be taken for histological evaluation and for&#xD;
      culture EmAs assay.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2014</start_date>
  <completion_date type="Actual">June 1, 2020</completion_date>
  <primary_completion_date type="Actual">October 1, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in the intestinal histology of NCWS patients who tested positives for EmAs in the culture medium of the intestinal biopsies, at the time of the first evaluation.</measure>
    <time_frame>At baseline and after at least one year since the initial NCWS diagnosis was posed.</time_frame>
    <description>Intestinal histology re-evaluation after at least one year since the initial NCWS diagnosis was posed. Marsh classification will be adopted: change from baseline (1st evaluation) to 2nd evaluation.&#xD;
The above parameter will be evaluated taking into account whether the patients adhered or not to a wheat-free diet.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum anti-tTG antibodies evaluation.</measure>
    <time_frame>At baseline and after at least one year since the initial NCWS diagnosis was posed.</time_frame>
    <description>Evaluation of changes in serum levels of anti-tTG antibodies after at least one year since the initial NCWS diagnosis was posed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum DPG antibodies evaluation.</measure>
    <time_frame>At baseline and after at least one year since the initial NCWS diagnosis was posed.</time_frame>
    <description>Evaluation of changes in serum levels of DPG antibodies after at least one year since the initial NCWS diagnosis was posed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum AGA evaluation.</measure>
    <time_frame>At baseline and after at least one year since the initial NCWS diagnosis was posed.</time_frame>
    <description>Evaluation of changes in serum levels of AGA after at least one year since the initial NCWS diagnosis was posed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence to a wheat-free diet</measure>
    <time_frame>At baseline and after at least one year since the initial NCWS diagnosis was posed.</time_frame>
    <description>Degree of adherence to a wheat-free diet since the initial diagnosis of NCWS was posed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptoms/signs evaluation.</measure>
    <time_frame>At baseline and after at least one year since the initial NCWS diagnosis was posed.</time_frame>
    <description>The evaluation of changes in symptoms/signs will be made according to the score calculated on the basis of the Visual Analogue Scale since the initial diagnosis of NCWS was posed.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">50</enrollment>
  <condition>Not-celiac Gluten Sensitivity</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <description>NCWS patients who had showed a negative celiac disease serology and a Marsh 0-1 duodenal histology, but who had displayed a positive EmA assay in the culture medium of the duodenal biopsies (EmA-biopsy).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>NCWS patients with negative EmA-biopsy.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The investigators will include exclusively patients who had been previously fully evaluated&#xD;
        for suspected celiac disease in our Hospitals (Department of Internal Medicine, Giovanni&#xD;
        Paolo II Hospital of Sciacca, Agrigento, and of Internal Medicine of the University of&#xD;
        Palermo) from January 2002 to December 2012. In all patients NCWS diagnosis had been posed&#xD;
        by means of a double-blind placebo-controlled (DBPC) challenge with wheat flour.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients, both genders, with age between 18-65 years, that has been previously&#xD;
             diagnosed as NCWS, according to a DBPC method&#xD;
&#xD;
          -  Patients testing negative for celiac disease ( anti-tTG and EMA negative, and with&#xD;
             biopsy Marsh 0-1) and wheat allergy (serum specific igE for wheat negative)&#xD;
&#xD;
          -  Patients showed positive EmAs in the culture medium of the duodenal biopsies&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects diagnosed with celiac disease (positive anti-tTG and/or EMA, and positive&#xD;
             histology, with Marsh 2 or above)&#xD;
&#xD;
          -  Subjects diagnosed with wheat allergy (positive serum specific IgE for wheat)&#xD;
&#xD;
          -  Subjects with Type 1 Diabetes&#xD;
&#xD;
          -  Subjects with Inflammatory Bowel Diseases (Crohn's disease or ulcerative colitis)&#xD;
&#xD;
          -  Subjects with Helicobacter pylori infection and other gastrointestinal infection&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio Carroccio, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Palermo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pasquale Mansueto, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Palermo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Internal Medicine, Giovanni Paolo II Hospital of Sciacca</name>
      <address>
        <city>Sciacca</city>
        <state>Agrigento</state>
        <zip>92019</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Internal Medicine, University Hospital of Palermo</name>
      <address>
        <city>Palermo</city>
        <zip>90129</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Carroccio A, Iacono G, Di Prima L, Pirrone G, Cavataio F, Ambrosiano G, Scium√® C, Geraci G, Florena A, Teresi S, Barbaria F, Pepe I, Campisi G, Mansueto P, Soresi M, Di Fede G. Antiendomysium antibodies assay in the culture medium of intestinal mucosa: an accurate method for celiac disease diagnosis. Eur J Gastroenterol Hepatol. 2011 Nov;23(11):1018-23. doi: 10.1097/MEG.0b013e328349b8a5.</citation>
    <PMID>21885984</PMID>
  </reference>
  <reference>
    <citation>Carroccio A, Iacono G, D'Amico D, Cavataio F, Teresi S, Caruso C, Di PL, Colombo A, D'Arpa F, Florena A, Notarbartolo A, Montalto G. Production of anti-endomysial antibodies in cultured duodenal mucosa: usefulness in coeliac disease diagnosis. Scand J Gastroenterol. 2002 Jan;37(1):32-8.</citation>
    <PMID>11843032</PMID>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>June 14, 2014</study_first_submitted>
  <study_first_submitted_qc>July 26, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 29, 2014</study_first_posted>
  <last_update_submitted>October 7, 2020</last_update_submitted>
  <last_update_submitted_qc>October 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Palermo</investigator_affiliation>
    <investigator_full_name>Pasquale Mansueto</investigator_full_name>
    <investigator_title>Researcher</investigator_title>
  </responsible_party>
  <keyword>Not-celiac gluten sensitivity</keyword>
  <keyword>Celiac Disease</keyword>
  <keyword>Gluten-free diet</keyword>
  <keyword>EMA assay</keyword>
  <keyword>Duodenal culture medium</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Celiac Disease</mesh_term>
    <mesh_term>Hypersensitivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

